NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 245 filers reported holding NEKTAR THERAPEUTICS in Q1 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $279,000 | +17.2% | 20,657 | +56.1% | 0.03% | +6.2% |
Q3 2021 | $238,000 | -65.5% | 13,231 | -67.1% | 0.03% | -65.2% |
Q2 2021 | $689,000 | -14.9% | 40,156 | -0.9% | 0.09% | -18.6% |
Q1 2021 | $810,000 | +27.8% | 40,506 | +8.6% | 0.11% | +18.9% |
Q4 2020 | $634,000 | +3.1% | 37,306 | +0.7% | 0.10% | -6.9% |
Q3 2020 | $615,000 | -26.7% | 37,056 | +2.3% | 0.10% | -31.5% |
Q2 2020 | $839,000 | +57.7% | 36,231 | +21.7% | 0.15% | +33.0% |
Q1 2020 | $532,000 | +25.8% | 29,781 | +51.9% | 0.11% | +62.3% |
Q4 2019 | $423,000 | – | 19,600 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Strong Tower Advisory Services | 404,972 | $6,913,000 | 4.02% |
GREAT POINT PARTNERS LLC | 504,691 | $9,064,000 | 2.11% |
Camber Capital Management LP | 3,750,000 | $67,350,000 | 2.07% |
ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,901,000 | 1.50% |
Rhenman & Partners Asset Management AB | 950,000 | $17,062,000 | 1.20% |
MAVERICK CAPITAL LTD | 5,838,426 | $104,858,000 | 1.06% |
Birchview Capital, LP | 72,000 | $1,293,000 | 0.88% |
Bellevue Group AG | 4,594,656 | $82,519,000 | 0.84% |
CM Management, LLC | 50,000 | $898,000 | 0.67% |
Duquesne Family Office | 1,000,000 | $17,960,000 | 0.58% |